# Pro-Resolving Mediators in Acute Inflammation in Humans

> **NCT04308889** · EARLY_PHASE1 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 19 (actual)

## Conditions studied

- Inflammation; Skin
- Resolution
- Blister

## Interventions

- **DRUG:** Lovaza
- **OTHER:** Cantharone
- **OTHER:** Phlebotomy

## Key facts

- **NCT ID:** NCT04308889
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-02
- **Primary completion:** 2022-02-03
- **Final completion:** 2022-02-22
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308889, "Pro-Resolving Mediators in Acute Inflammation in Humans". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04308889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*